2030년까지 중남미 형질감염 시약 및 장비 시장 예측 - 지역 분석 - 제품별(시약 및 기기), 방법(바이러스 방법, 비바이러스 방법 및 하이브리드 방법), 응용 분야(생의학 연구, 단백질 생산 및 치료 전달) 및 최종 사용자(학술 및 연구 기관, 제약 및 생명공학 회사)
세계보건기구(WHO)에 따르면, 암 연료의 경제적 부담 증가 중남미 형질감염 시약 및 장비 시장
WHO)에 따르면 암은 전 세계적으로 주요 사망 원인 중 하나이며 2020년에는 약 1,000만명의 사망자를 기록했습니다. 국제암연구소(International Agency for Research on Cancer)에 따르면 전 세계 암 부담은 3,020만명이 더 추가되면서 증가할 것으로 예상됩니다. 유방암 협회(Breast Cancer Organization)에 따르면 전세계 유방암 사례의 약 5~10%는 유전성이고 여러 세대에 걸쳐 전달되는 비정상 유전자에 의해 발생합니다. 2023년 국제 역학 저널(International Journal of Epidemiology)에 게재된 \"생활 방식, 유전적 위험 및 암 발병률\"이라는 기사에 따르면 발생하는 암 상태의 거의 33%가 유전적이며, 이 질병에서 유전적 돌연변이의 위험이 높습니다. 따라서 사람들은 유전성 암의 조기 발견과 맞춤형 치료를 위해 유전자 프로파일링을 선택하고 있습니다. BRCA1 및 BRCA2는 때때로 종양 억제 유전자라고도 합니다. 이러한 유전자 중 하나의 해로운 변종을 물려받은 사람들은 여러 암, 특히 유방암과 난소암에 걸릴 위험이 더 높습니다. 또한 이 사람들은 해당 유전자에 변이가 없는 사람들에 비해 더 어린 나이에 암이 발병하는 경향이 있습니다. 암세포의 핵산 처리에 초점을 맞춘 연구는 암 대사를 이해하는 데 도움이 될 것입니다. DNA는 일반적으로 형질감염될 세포로 전달되도록 바이러스 또는 비바이러스 입자로 포장됩니다. 난치성 또는 전이성 암 치료에서 항종양제의 효과를 높이기 위한 새로운 접근법으로 유전자 전달이 제안되었습니다. 유전자 요법과 약물(유사 요법)의 연관성은 특히 폐암, 대장암, 췌장암, 방광암 및 유방암에서 기존 치료법의 항증식 효과를 강화시키는 것으로 보고되었습니다. 따라서 암의 경제적 부담 증가는 중남미 형질감염 시약 및 장비 시장을 강화합니다.
남미 및 중미 형질감염 시약 및 장비 시장 개요
남미 및 중미 지역은 브라질, 아르헨티나 및 기타 중남미 지역으로 구분됩니다. 브라질은 2022년에 지역 점유율의 절반 이상을 차지했습니다.
브라질은 유리한 경제 정책과 개혁, 국내 의약품 생산의 확고한 입지, 의료비 지출 증가로 인해 제약 산업에서 상당한 발전을 이루었습니다. . 국제 무역청(ITA)에 따르면 브라질은 라틴 아메리카에서 가장 큰 의료 시장이며 GDP의 9.1%를 의료에 지출합니다. 국내 기업이 국내 의약품 총생산을 장악하고 있어 무역 활동이 가능하다. 미국 상무부에 따르면 국내 기업은 브라질 제약회사 전체의 약 80%를 차지한다. 따라서 성장하는 제약 산업 환경은 브라질의 Transfection 시약 및 장비 시장 성장의 주요 요인 중 하나입니다.
게다가 아르헨티나는 중남미에서 브라질에 이어 가장 큰 제약 산업을 보유하고 있습니다. 국내 형질감염 시약 및 장비 시장 성장은 광범위한 연구 개발 노력과 국내 의약품 생산 증가에 의해 크게 좌우됩니다. 건강 상태의 불확실성 증가, 제약 산업에 대한 점점 더 강력해지는 규제 환경, 원자재 물류 개선으로 인해 제약 및 바이오의약품에 대한 수요 증가는 예측 기간 동안 아르헨티나의 형질감염 시약 및 장비 시장의 성장을 촉진할 가능성이 높습니다. .
중미 형질감염 시약 및 장비 시장은 제품, 방법, 응용 프로그램, 최종 사용자 및 국가를 기준으로 분류됩니다.
제품을 기준으로 남미 및 중미 형질주입 시약 및 장비 시장은 시약 및 기기로 구분됩니다. 2022년에는 시약 부문이 더 큰 점유율을 차지했습니다.
방법 측면에서 중남미 형질감염 시약 및 장비 시장은 바이러스 방법, 비바이러스 방법, 하이브리드 방법으로 분류됩니다. 비바이러스 방법 부문은 2022년에 가장 큰 점유율을 차지했습니다. 바이러스 부문은 레트로바이러스, 아데노바이러스, 아데노 관련 바이러스 및 헤르페스 바이러스로 하위 분류됩니다. 비바이러스성 부분은 물리적/기계적 방법과 화학적 방법으로 구분됩니다. 또한 물리적/기계적 방법은 전기천공법, 미세주입법, 생물학적 방법, 레이저법, 자기감염법, 초음파천공법으로 분류됩니다. 또한 화학적 방법 부문은 리포솜 기반/고지질 기반과 비리포솜/고지질 기반으로 하위 분류됩니다.
응용 분야에 따라 중남미 형질주입 시약 및 장비 시장은 생물 의학 연구, 단백질 생산 및 치료 전달로 분류됩니다. 2022년에는 생의학 연구 부문이 가장 큰 점유율을 차지했습니다.
최종 사용자를 기준으로 중남미 형질주입 시약 및 장비 시장은 학계 및 연구 기관과 제약 및 생명공학 회사로 구분됩니다. 2022년에는 학계 및 연구 기관 부문이 더 큰 점유율을 차지했습니다.
국가별로 중남미 형질감염 시약 및 장비 시장은 브라질, 아르헨티나, 중남미 나머지 지역으로 분류됩니다. 브라질은 2022년 중남미 형질감염 시약 및 장비 시장을 장악했습니다.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG 및 MaxCyte Inc는 중남미 형질주입 시약 및 장비 시장에서 활동하는 선도적인 회사입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - South & Central America Market Analysis
5.1 South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
6. South & Central America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market -Country Analysis
10.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Brazil: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Brazil: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Argentina: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Argentina: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. South & Central America Transfection Reagents and Equipment Market Segmentation
Table 2. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. South & Central America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. South & Central America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. South & Central America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. South & Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.